Clinical Trial

Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression

Name: Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression — clinical trial record (NCT07324070)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RMTSECT2

Recruiting

View on ClinicalTrials.gov →

Summary

The RTMSECT2 study was design to compare the application of electroconvulsive therapy augmented by transcranial magnetic stimulation. Subject will be compared both within groups and in group using psychometric scales and different deliver energy

Trial Details

NCT Number	NCT07324070
Lead Sponsor	Charles University, Czech Republic
Conditions	Major Depressive Disorder (MDD), Treatment Resistant Depression (TRD)
Enrollment	50 participants
Start Date	2026-01-05
Primary Completion	2028-01-05 (estimated)
Study Completion	2029-01-05 (estimated)
Updated on ClinicalTrials.gov	2026-01-07